Mai Capital Management Takeda Pharmaceutical CO LTD Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mai Capital Management holds 1,657 shares of TAK stock, worth $23,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,657
Previous 1,597
3.76%
Holding current value
$23,579
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TAK
# of Institutions
359Shares Held
67.3MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$188 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$81.1 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$75.7 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$49.9 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$48.9 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...